Status:
UNKNOWN
The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Collaborating Sponsors:
Severance Hospital
Conditions:
Early Puberty
Eligibility:
FEMALE
40+ years
Phase:
PHASE1
Brief Summary
A randomized, single-blinded, parallel design phase I clinical trial to investigate the safety and pharmacokinetics/pharmacodynamics of CKD-841 A-1, CKD-841 D or Leuplin Inj. after subcutaneous inject...
Detailed Description
To investigate the safety and pharmacokinetics/pharmacodynamics of CKD-841 A-1, CKD-841 D or Leuplin Inj. 3.75 mg after subcutaneous injection in postmenopausal female
Eligibility Criteria
Inclusion
- Healthy menopausal female
- β-hCG is negative at screening and before administration of investigational drug
- Infertility by sterilization operation before 5 months from screening excluding ovarian cancer, uterine cancer etc.
- Bwt ≥ 50Kg and Body Mass Index (BMI) ≥ 18.5 and \< 28.0
Exclusion
- History or current condition of disease related to Hepato-biliary system, renal system, nervous system, mental illness, immune system, respiratory system, endocrine system, hemato-oncology, circulatory system, musculoskeletal system or except for that, significant clinical disease
- Uncontrolled diabetes mellitus in the last three months
- Pregnancy or breast feeding
- History of taking medicine such as Leuprorelin acetate or similar affiliation drug within 12 weeks before administration of investigational drug
- Has hypersensitivity to the active ingredient or excipients or same affiliation drug of the investigational drug, hypersensitivity of a medicine contained gelatin especially
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04840745
Start Date
April 1 2021
End Date
November 1 2021
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, Yonsei-ro, Seodaemun-gu 50-1, South Korea, 03722